News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PSI CRO Further Strengthens Capabilities In Infectious Diseases Clinical Trials



9/4/2014 10:31:13 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ZUG, Switzerland--(BUSINESS WIRE)--PSI CRO, a full-service contract research organization, mentioned today that they are strengthening their clinical trial management approaches in the area of Infectious Diseases.

A therapeutically aligned infectious diseases team will support all ID studies at PSI, focused to provide optimized approaches to patient enrollment. The team will include staff from various departments including Feasibility, Medical Affairs and Project Management.

PSI has continued to grow their Infectious Diseases experience that includes new and ongoing global studies in pneumonias, complicated urinary tract infections, intra-abdominal infections, skin infections, sepsis, and other indications. In the recent weeks, PSI reached an interim enrollment objective of several hundred patients in a global community acquired pneumonia trial, completed a global trial in a complicated urinary tract infection trial, fully enrolled a Phase III intra-abdominal infection study, as well as a trial of an influenza vaccine.

Hey, check out all the research scientist jobs. Post your resume today!

Read at BioSpace.com


comments powered by Disqus
PSI CRO
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES